Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?

Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?

There are three prognostic stratification tools used for endometrial cancer: ESMO-ESGO-ESTRO 2016, ProMisE, and ESGO-ESTRO-ESP 2020. However, these methods are not sufficiently accurate to address prognosis. The aim of this study was to investigate whether the integration of molecular classification...

Full description

Bibliographic Details
Main Authors: Jorge Luis Ramon-Patino, Ignacio Ruz-Caracuel, Victoria Heredia-Soto, Luis Eduardo Garcia de la Calle, Bulat Zagidullin, Yinyin Wang, Alberto Berjon, Alvaro Lopez-Janeiro, Maria Miguel, Javier Escudero, Alejandro Gallego, Beatriz Castelo, Laura Yebenes, Alicia Hernandez, Jaime Feliu, Alberto Pelaez-García, Jing Tang, David Hardisson, Marta Mendiola, Andres Redondo
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
endometrial cancer
prognosis
risk assessment
biomarkers
<i>CTNNB1</i>
Online Access:https://www.mdpi.com/2072-6694/14/4/912

Internet

https://www.mdpi.com/2072-6694/14/4/912

Similar Items